$1.03 Billion is the total value of Nantahala Capital Management's 124 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 37.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARES TRput | $131,089,000 | -27.2% | 700,000 | -30.7% | 12.68% | -8.2% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $126,464,285 | -0.3% | 1,843,234 | -1.5% | 12.23% | +25.8% |
| CASH | Buy | PATHWARD FINANCIAL INC | $65,075,857 | +17.1% | 1,403,707 | +4.8% | 6.29% | +47.7% |
| IMAX | Sell | IMAX CORP | $50,033,460 | -14.6% | 2,944,877 | -3.6% | 4.84% | +7.8% |
| QURE | Sell | UNIQURE NV | $32,649,357 | -47.2% | 2,848,984 | -7.2% | 3.16% | -33.4% |
| LXFR | Sell | LUXFER HLDGS PLC | $31,639,537 | -24.0% | 2,223,439 | -9.8% | 3.06% | -4.1% |
| IMTX | Sell | IMMATICS N.V | $26,367,688 | +39.0% | 2,284,895 | -16.9% | 2.55% | +75.5% |
| RDVT | Sell | RED VIOLET INC | $26,074,820 | +13.0% | 1,267,614 | -3.3% | 2.52% | +42.6% |
| HGV | Buy | HILTON GRAND VACATIONS INC | $20,033,542 | +9.9% | 440,879 | +7.5% | 1.94% | +38.7% |
| KROS | Sell | KEROS THERAPEUTICS INC | $19,975,929 | -37.0% | 497,161 | -33.1% | 1.93% | -20.5% |
| VMD | Buy | VIEMED HEALTHCARE INC | $16,904,681 | +9.9% | 1,728,495 | +8.5% | 1.64% | +38.7% |
| LYRA | Buy | LYRA THERAPEUTICS INC | $16,265,497 | +264.4% | 3,957,542 | +78.2% | 1.57% | +359.9% |
| BVS | Buy | BIOVENTUS INC | $16,234,939 | +193.3% | 5,617,626 | +8.6% | 1.57% | +270.3% |
| RMR | Sell | RMR GROUP INCcl a | $16,203,476 | -24.9% | 699,330 | -14.9% | 1.57% | -5.2% |
| RMBL | Sell | RUMBLEON INC | $15,713,898 | +65.7% | 1,271,351 | -18.8% | 1.52% | +109.1% |
| CDXS | Sell | CODEXIS INC | $14,099,856 | -33.9% | 5,035,663 | -2.2% | 1.36% | -16.5% |
| GDEN | Sell | GOLDEN ENTMT INC | $13,880,233 | -9.7% | 332,063 | -6.0% | 1.34% | +13.9% |
| PTON | Sell | PELOTON INTERACTIVE INC | $13,552,172 | -51.4% | 1,762,311 | -28.3% | 1.31% | -38.6% |
| TBBK | New | BANCORP INC DEL | $13,319,437 | – | 407,946 | +100.0% | 1.29% | – |
| RH | RHcall | $13,183,600 | +35.3% | 40,000 | 0.0% | 1.28% | +70.7% | |
| MAX | Buy | MEDIAALPHA INCcl a | $11,784,175 | -27.6% | 1,142,985 | +5.2% | 1.14% | -8.7% |
| DHX | Sell | DHI GROUP INC | $11,605,658 | -12.4% | 3,030,198 | -11.3% | 1.12% | +10.5% |
| IWM | Sell | ISHARES TRrussell 2000 etf | $10,612,965 | -68.9% | 56,672 | -70.3% | 1.03% | -60.7% |
| CRMT | Buy | AMERICAS CAR-MART INC | $10,594,441 | +108.8% | 106,178 | +65.7% | 1.02% | +163.5% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $10,167,843 | -28.2% | 4,272,203 | -44.5% | 0.98% | -9.3% |
| Sell | AURA BIOSCIENCES INC | $9,921,064 | +26.8% | 803,325 | -4.8% | 0.96% | +59.8% | |
| DARIOHEALTH CORP | $9,698,212 | -2.7% | 2,418,507 | 0.0% | 0.94% | +22.8% | ||
| IWM | New | ISHARES TRcall | $9,363,500 | – | 50,000 | +100.0% | 0.90% | – |
| MLHR | Sell | MILLERKNOLL INC | $8,984,511 | -53.0% | 607,883 | -34.9% | 0.87% | -40.6% |
| BXMT | New | BLACKSTONE MTG TR INCput | $8,324,000 | – | 400,000 | +100.0% | 0.80% | – |
| HLF | HERBALIFE LTDcall | $7,944,000 | -17.8% | 600,000 | 0.0% | 0.77% | +3.8% | |
| DXPE | Sell | DXP ENTERPRISES INC | $7,779,798 | -14.5% | 213,672 | -36.8% | 0.75% | +7.9% |
| ILPT | Buy | INDUSTRIAL LOGISTICS PPTYS T | $7,779,037 | +101.1% | 2,357,284 | +87.0% | 0.75% | +154.1% |
| PAYO | Buy | PAYONEER GLOBAL INC | $7,757,866 | -18.2% | 1,612,862 | +6.8% | 0.75% | +3.2% |
| RDI | Sell | READING INTL INCcl a | $7,646,612 | -18.7% | 2,885,514 | -0.4% | 0.74% | +2.5% |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $7,327,332 | -26.3% | 422,812 | -32.6% | 0.71% | -7.0% |
| ZM | ZOOM VIDEO COMMUNICATIONS INcall | $6,788,000 | -8.1% | 100,000 | 0.0% | 0.66% | +15.9% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $6,763,195 | -67.2% | 323,134 | -66.9% | 0.65% | -58.6% |
| DYN | Buy | DYNE THERAPEUTICS INC | $6,673,095 | +223.8% | 593,164 | +231.6% | 0.64% | +308.2% |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $6,662,846 | +858.7% | 2,149,305 | +329.9% | 0.64% | +1115.1% |
| KRTX | New | KARUNA THERAPEUTICS INCcall | $6,505,500 | – | 30,000 | +100.0% | 0.63% | – |
| EHTH | Buy | EHEALTH INC | $6,432,000 | +71.8% | 800,000 | +100.0% | 0.62% | +116.7% |
| VENTYX BIOSCIENCES INC | $6,319,609 | -2.1% | 192,671 | 0.0% | 0.61% | +23.4% | ||
| RMBL | New | RUMBLEON INCcall | $6,180,000 | – | 500,000 | +100.0% | 0.60% | – |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $6,058,712 | -61.2% | 553,307 | -69.1% | 0.59% | -51.0% |
| PTON | PELOTON INTERACTIVE INCcall | $5,998,200 | -32.2% | 780,000 | 0.0% | 0.58% | -14.5% | |
| CYTK | Buy | CYTOKINETICS INC | $5,847,363 | +453.9% | 179,257 | +497.5% | 0.56% | +597.5% |
| Sell | ABEONA THERAPEUTICS INC | $5,649,577 | +40.2% | 1,401,880 | -1.9% | 0.55% | +76.7% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $5,184,050 | +24.6% | 572,191 | 0.0% | 0.50% | +57.1% | |
| NSPR | New | INSPIREMD INC | $4,669,617 | – | 1,860,405 | +100.0% | 0.45% | – |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $4,476,945 | -25.5% | 3,961,898 | -16.2% | 0.43% | -5.9% |
| QURE | UNIQURE NVcall | $4,443,042 | -43.1% | 387,700 | 0.0% | 0.43% | -28.1% | |
| TALS | New | TALARIS THERAPEUTICS INC | $4,408,103 | – | 1,450,034 | +100.0% | 0.43% | – |
| IMAX | IMAX CORPcall | $4,247,500 | -11.4% | 250,000 | 0.0% | 0.41% | +12.0% | |
| SSKN | STRATA SKIN SCIENCES INC | $4,173,561 | -10.3% | 4,393,685 | 0.0% | 0.40% | +13.5% | |
| PAR TECHNOLOGY CORPnote 2.875% 4/1 | $4,048,531 | +0.0% | 3,785,000 | 0.0% | 0.39% | +26.5% | ||
| CVNA | CARVANA COcall | $3,888,000 | +164.8% | 150,000 | 0.0% | 0.38% | +232.7% | |
| MGTA | New | MAGENTA THERAPEUTICS INC | $3,790,000 | – | 5,000,000 | +100.0% | 0.37% | – |
| TELA | Buy | TELA BIO INC | $3,607,212 | +32.4% | 356,092 | +39.0% | 0.35% | +67.0% |
| New | AMYLYX PHARMACEUTICALS INC | $3,548,265 | – | 164,500 | +100.0% | 0.34% | – | |
| FBIO | Sell | FORTRESS BIOTECH INC | $3,514,888 | -38.0% | 6,390,706 | -7.6% | 0.34% | -21.8% |
| UTHR | UNITED THERAPEUTICS CORP DEL | $3,465,775 | -1.4% | 15,700 | 0.0% | 0.34% | +24.5% | |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $3,427,710 | -1.5% | 145,860 | -42.5% | 0.33% | +24.0% |
| Buy | JASPER THERAPEUTICS INC | $3,394,696 | +11.1% | 2,477,880 | +46.8% | 0.33% | +40.2% | |
| NDLS | New | NOODLES & CO | $3,380,000 | – | 1,000,000 | +100.0% | 0.33% | – |
| OPTN | Buy | OPTINOSE INC | $3,298,450 | +17.9% | 2,681,667 | +84.9% | 0.32% | +49.1% |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $3,234,411 | +127.8% | 986,101 | 0.0% | 0.31% | +187.2% | |
| AGS | Buy | PLAYAGS INC | $3,121,698 | -12.1% | 552,513 | +11.3% | 0.30% | +11.0% |
| RILY | B. RILEY FINANCIAL INC | $2,874,670 | +62.0% | 62,520 | 0.0% | 0.28% | +104.4% | |
| ENVA | ENOVA INTL INC | $2,828,640 | +19.6% | 53,250 | 0.0% | 0.27% | +51.4% | |
| Sell | SOLENO THERAPEUTICS INC | $2,787,818 | +86.3% | 649,841 | -7.1% | 0.27% | +134.8% | |
| CCCC | New | C4 THERAPEUTICS INC | $2,750,000 | – | 1,000,000 | +100.0% | 0.27% | – |
| FOSL | New | FOSSIL GROUP INC | $2,364,863 | – | 920,180 | +100.0% | 0.23% | – |
| SRL | Sell | SCULLY ROYALTY LTD | $2,211,198 | +6.3% | 303,736 | -2.2% | 0.21% | +34.6% |
| PWP | Sell | PERELLA WEINBERG PARTNERS | $2,151,414 | -53.2% | 258,273 | -48.9% | 0.21% | -40.9% |
| STRUCTURE THERAPEUTICS INCsponsored ads | $2,078,500 | +74.7% | 50,000 | 0.0% | 0.20% | +120.9% | ||
| AAN | Sell | THE AARONS COMPANY INC | $1,959,408 | -29.7% | 138,572 | -52.0% | 0.19% | -11.7% |
| NPCE | Sell | NEUROPACE INC | $1,907,576 | -3.5% | 424,850 | -0.3% | 0.18% | +21.9% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $1,847,587 | +39.8% | 4,101,193 | -10.0% | 0.18% | +77.2% |
| ADCT | ADC THERAPEUTICS SA | $1,806,000 | +10.3% | 840,000 | 0.0% | 0.18% | +38.9% | |
| Buy | AYTU BIOPHARMA INC | $1,738,899 | +185.8% | 1,086,812 | +300.2% | 0.17% | +257.4% | |
| EHTH | Buy | EHEALTH INCcall | $1,632,924 | +17.4% | 203,100 | +36.7% | 0.16% | +47.7% |
| AVTE | AEROVATE THERAPEUTICS INC | $1,629,250 | -15.0% | 95,000 | 0.0% | 0.16% | +7.5% | |
| RZLT | REZOLUTE INC | $1,523,820 | +3.1% | 769,606 | 0.0% | 0.15% | +30.1% | |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $1,367,120 | -41.8% | 111,148 | -41.9% | 0.13% | -26.7% |
| NNBR | New | NN INC | $1,257,154 | – | 526,006 | +100.0% | 0.12% | – |
| SBTX | New | ARS PHARMACEUTICALS INC | $1,206,650 | – | 180,097 | +100.0% | 0.12% | – |
| ANEB | ANEBULO PHARMACEUTICALS INC | $1,201,022 | -19.0% | 511,073 | 0.0% | 0.12% | +1.8% | |
| SELB | SELECTA BIOSCIENCES INC | $1,120,000 | -19.4% | 1,000,000 | 0.0% | 0.11% | +0.9% | |
| ACER | Sell | ACER THERAPEUTICS INC | $1,049,367 | +15.0% | 1,136,416 | -5.5% | 0.10% | +44.3% |
| SGRP | Buy | SPAR GROUP INC | $955,120 | +6.3% | 758,032 | +8.8% | 0.09% | +33.3% |
| TNL | Sell | TRAVEL PLUS LEISURE CO | $928,465 | -96.2% | 23,016 | -96.3% | 0.09% | -95.2% |
| New | ELICIO THERAPEUTICS INC | $901,920 | – | 94,939 | +100.0% | 0.09% | – | |
| DHC | Sell | DIVERSIFIED HEALTHCARE TR | $890,129 | -87.8% | 395,613 | -92.7% | 0.09% | -84.6% |
| SCYX | SCYNEXIS INC | $885,000 | -1.7% | 300,000 | 0.0% | 0.09% | +24.6% | |
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $827,003 | -38.8% | 1,251,139 | -27.4% | 0.08% | -23.1% |
| UNICYCIVE THERAPEUTICS INC | $828,692 | -39.0% | 647,416 | 0.0% | 0.08% | -23.1% | ||
| COGT | New | COGENT BIOSCIENCES INC | $759,323 | – | 64,132 | +100.0% | 0.07% | – |
| New | BERKSHIRE GREY INC | $705,000 | – | 500,000 | +100.0% | 0.07% | – | |
| New | APTOSE BIOSCIENCES INC | $678,516 | – | 146,232 | +100.0% | 0.07% | – | |
| CVNA | New | CARVANA COcl a | $648,000 | – | 25,000 | +100.0% | 0.06% | – |
| SRTS | SENSUS HEALTHCARE INC | $582,901 | -39.5% | 185,048 | 0.0% | 0.06% | -24.3% | |
| KROS | KEROS THERAPEUTICS INCcall | $494,214 | -5.9% | 12,300 | 0.0% | 0.05% | +20.0% | |
| TACT | Sell | TRANSACT TECHNOLOGIES INC | $353,920 | -5.9% | 39,500 | -35.0% | 0.03% | +17.2% |
| XGN | Sell | EXAGEN INC | $353,493 | +9.7% | 121,894 | -8.1% | 0.03% | +36.0% |
| AKUMIN INC | $339,634 | -73.5% | 1,886,856 | 0.0% | 0.03% | -66.3% | ||
| LADR | New | LADDER CAP CORPcl a | $293,742 | – | 27,073 | +100.0% | 0.03% | – |
| Sell | LUCID DIAGNOSTICS INC | $276,713 | -26.6% | 199,074 | -23.9% | 0.03% | -6.9% | |
| Sell | JOURNEY MED CORP | $284,143 | -14.8% | 178,706 | -15.8% | 0.03% | +3.8% | |
| EARGO INC | $266,230 | +5.3% | 54,002 | 0.0% | 0.03% | +36.8% | ||
| BMTX | BM TECHNOLOGIES INC | $236,052 | -15.3% | 79,212 | 0.0% | 0.02% | +9.5% | |
| Sell | AVALO THERAPEUTICS INC | $197,563 | -86.0% | 556,202 | -31.2% | 0.02% | -82.4% | |
| RFL | RAFAEL HLDGS INC | $151,897 | +34.8% | 72,678 | 0.0% | 0.02% | +66.7% | |
| EBET INC | $125,721 | -71.3% | 1,065,432 | 0.0% | 0.01% | -64.7% | ||
| New | NOGIN INC*w exp 08/26/202 | $111,815 | – | 330,000 | +100.0% | 0.01% | – | |
| CUE | Sell | CUE BIOPHARMA INC | $97,674 | -70.7% | 26,760 | -71.3% | 0.01% | -65.4% |
| New | ABEONA THERAPEUTICS INCcall | $80,600 | – | 20,000 | +100.0% | 0.01% | – | |
| FULC | FULCRUM THERAPEUTICS INC | $70,521 | +15.8% | 21,370 | 0.0% | 0.01% | +40.0% | |
| New | NOGIN INC | $73,917 | – | 56,425 | +100.0% | 0.01% | – | |
| GUARDFORCE AI CO LTD*w exp 10/01/202 | $50,888 | +64.9% | 154,205 | 0.0% | 0.01% | +150.0% | ||
| GAIA | GAIA INC NEWcl a | $53,463 | -16.9% | 23,144 | 0.0% | 0.01% | 0.0% | |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $23,838 | -28.2% | 67,800 | -57.7% | 0.00% | -33.3% |
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $10,118 | -57.0% | 235,294 | 0.0% | 0.00% | -50.0% | ||
| IMAC | Sell | IMAC HLDGS INC | $5,931 | -96.0% | 53,918 | -94.8% | 0.00% | -90.9% |
| Exit | QUALTEK SERVICES INC*w exp 02/14/202 | $0 | – | -96,244 | -100.0% | 0.00% | – | |
| Exit | LUCY SCIENTIFIC DISCOVERY IN | $0 | – | -95,800 | -100.0% | -0.01% | – | |
| CRIS | Exit | CURIS INC | $0 | – | -230,614 | -100.0% | -0.01% | – |
| ANGN | Exit | ANGION BIOMEDICA CORP | $0 | – | -982,743 | -100.0% | -0.04% | – |
| Exit | HYPERFINE INC | $0 | – | -368,417 | -100.0% | -0.04% | – | |
| IDWM | Exit | IDW MEDIA HLDGS INCcl b | $0 | – | -822,537 | -100.0% | -0.04% | – |
| LNDC | Exit | LIFECORE BIOMEDICAL INC | $0 | – | -194,700 | -100.0% | -0.06% | – |
| WNC | Exit | WABASH NATL CORPput | $0 | – | -50,000 | -100.0% | -0.09% | – |
| DAKT | Exit | DAKTRONICS INC | $0 | – | -292,187 | -100.0% | -0.13% | – |
| Exit | DISC MEDICINE INC | $0 | – | -89,538 | -100.0% | -0.14% | – | |
| KRE | Exit | SPDR SER TRcall | $0 | – | -50,000 | -100.0% | -0.17% | – |
| MED | Exit | MEDIFAST INC | $0 | – | -30,000 | -100.0% | -0.24% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -4,978,975 | -100.0% | -0.24% | – | |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -200,700 | -100.0% | -0.26% | – |
| RNG | Exit | RINGCENTRAL INCcl a | $0 | – | -137,622 | -100.0% | -0.32% | – |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -1,529,100 | -100.0% | -0.40% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INCcall | $0 | – | -100,000 | -100.0% | -0.52% | – |
| Exit | CVENT HOLDING CORP | $0 | – | -845,000 | -100.0% | -0.54% | – | |
| RH | Exit | RH | $0 | – | -36,060 | -100.0% | -0.67% | – |
| AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -820,825 | -100.0% | -0.92% | – |
| APEN | Exit | APOLLO ENDOSURGERY INCcall | $0 | – | -2,000,000 | -100.0% | -1.52% | – |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -4,575,021 | -100.0% | -3.48% | – |
| TA | Exit | TRAVELCENTERS OF AMERICA INC | $0 | – | -598,210 | -100.0% | -3.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 45 | Q2 2024 | 27.2% |
| CODEXIS INC | 45 | Q2 2024 | 3.9% |
| PATHWARD FINANCIAL INC | 38 | Q2 2024 | 6.3% |
| GOLDEN ENTMT INC | 35 | Q1 2024 | 2.1% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| UNIQURE NV | 31 | Q2 2024 | 4.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 18, 2024 | 1,086,812 | 18.2% |
| Rezolute, Inc. | March 11, 2024 | 4,118,164 | 9.9% |
| ABEONA THERAPEUTICS INC. | February 14, 2024 | 2,499,781 | 9.9% |
| Aptose Biosciences Inc. | February 14, 2024 | 120,132 | 1.5% |
| Assertio Holdings, Inc. | February 14, 2024 | 7,619,440 | 8.0% |
| Avalo Therapeutics, Inc. | February 14, 2024 | 42,100 | 4.9% |
| Bioventus Inc. | February 14, 2024 | 5,977,471 | 9.5% |
| Cellectar Biosciences, Inc. | February 14, 2024 | 3,229,903 | 9.9% |
| Cidara Therapeutics, Inc. | February 14, 2024 | 1,546,745 | 1.7% |
| CODEXIS, INC. | February 14, 2024 | 4,592,903 | 6.6% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| SC 13G/A | 2024-08-30 |
| 13F-HR/A | 2024-08-20 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-07-03 |
| 4 | 2024-06-18 |
| SC 13D/A | 2024-06-18 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.